HK1164883A1 - Carvedilol sulfate crystals, preparation methods and pharmaceutical use thereof - Google Patents

Carvedilol sulfate crystals, preparation methods and pharmaceutical use thereof

Info

Publication number
HK1164883A1
HK1164883A1 HK12105807.8A HK12105807A HK1164883A1 HK 1164883 A1 HK1164883 A1 HK 1164883A1 HK 12105807 A HK12105807 A HK 12105807A HK 1164883 A1 HK1164883 A1 HK 1164883A1
Authority
HK
Hong Kong
Prior art keywords
preparation methods
pharmaceutical use
sulfate crystals
carvedilol sulfate
carvedilol
Prior art date
Application number
HK12105807.8A
Original Assignee
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co filed Critical Jiangsu Hengrui Medicine Co
Publication of HK1164883A1 publication Critical patent/HK1164883A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK12105807.8A 2010-07-26 2012-06-14 Carvedilol sulfate crystals, preparation methods and pharmaceutical use thereof HK1164883A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102378844A CN102336701B (en) 2010-07-26 2010-07-26 Carvedilol sulphate crystals, preparation method and application thereof in medicine

Publications (1)

Publication Number Publication Date
HK1164883A1 true HK1164883A1 (en) 2012-09-28

Family

ID=45512701

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105807.8A HK1164883A1 (en) 2010-07-26 2012-06-14 Carvedilol sulfate crystals, preparation methods and pharmaceutical use thereof

Country Status (3)

Country Link
CN (1) CN102336701B (en)
HK (1) HK1164883A1 (en)
WO (1) WO2012013118A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103373952B (en) * 2012-04-11 2017-02-08 江苏恒瑞医药股份有限公司 New crystal forms of carvedilol sulfate
CN103467363A (en) * 2013-09-27 2013-12-25 中国药科大学 Carvedilol-asccharin amorphous compound
CN110668994A (en) * 2019-11-12 2020-01-10 山东创新药物研发有限公司 Levaldecolonite crystal form, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512350A (en) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド Carvedilol composition treatment and delivery methods
JP2007512372A (en) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド Carvedilol salts, corresponding compositions, delivery and / or treatment methods
US8734850B2 (en) * 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form

Also Published As

Publication number Publication date
WO2012013118A1 (en) 2012-02-02
CN102336701A (en) 2012-02-01
CN102336701B (en) 2013-09-18

Similar Documents

Publication Publication Date Title
IL231386A (en) Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
SI2627268T1 (en) Medical devices with detachable pivotable jaws
GB2488918B (en) Sugar mixtures and methods for production and use thereof
ZA201300685B (en) Anticancer derivatives,preparation thereof and therapeutic use thereof
PT2655375E (en) Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
IL225972A0 (en) Salts of kukoamine b, preparation method and use thereof
EP2718283A4 (en) Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
IL231444A0 (en) Aniline derivativs, their preparation and their therapeutic application
EP2738237A4 (en) Amphiphilic macromolecule and use thereof
EP2573072A4 (en) Indenoquinolone compound, preparation method and use thereof
EP2757092A4 (en) Substituted cyanoaniline compounds, preparation and use thereof
GB201011411D0 (en) Therapeutic compounds and their use
ZA201206740B (en) Aildenafil citrate crystal form o,preparation method and use thereof
IL233238A (en) Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
EP2581099A4 (en) Intervention medical device and preparation thereof
HK1164883A1 (en) Carvedilol sulfate crystals, preparation methods and pharmaceutical use thereof
HK1164861A1 (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
EP2626347A4 (en) Dalfampridine polymorph, preparation therefor, and application thereof
EP2653520A4 (en) Halo-borate fluorescent materials and preparation methods thereof
SI2421864T1 (en) 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof
IL226388A0 (en) Novel indolizine derivatives, and preparation and therapeutic use thereof
IL220859A0 (en) Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application
EP2621490A4 (en) Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use
ZA201108148B (en) Triazine-aryl-bis-indoles and process for preparation thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220724